About us
Profile
Contributors
Staff
Address
Contact Us
Articles
Canada
USA
International
Topics
Access to Medicines
Innovation
Comparative Effectiveness
Health Technology Assessment
Importation
Global Public Health
Emerging Markets
Patient Safety
Patient Advocacy
Events
Publications
Presentations
Reports and Research Papers
Register
Home
|
Topics
| Access to Medicines
usa
11.
At least Two-Thirds of Foreign Drug Manufacturers that Export to the U.S. Have Never Been Inspected by the FDA
12.
Sales of Imported Drugs Drop 80 Percent as Americans Abandon Risky Drug Importation
13.
As lawmakers consider making it easier to import foreign drugs nearly two-thirds of Americans lack confidence in foreign manufactured prescription drugs
14.
Institutional, physician and clinical services accounts for nearly 70% of U.S. personal health spending growth over the past 5 years
15.
Encouraging consumers to import foreign drugs puts american patients at risk
16.
Les aînés américains ont un meilleur accès aux médicaments sur ordonnance dans le cadre du régime Medicare Part D que les aînés canadiens sous les régimes d’assurance-médicaments subventionnés par l’État
17.
American seniors have better access to prescription drugs under Medicare Part D plans than Canadian seniors under Canadian publicly funded drug plans
18.
Seniors express high level of satisfaction with Medicare drug benefit
19.
Non-drug medical costs accounted for 70 percent of average health premium increase in 2005
20.
Keeping workers healthy reduces lost productivity from unmanaged illness
<<
Start
<
Prev
1
2
3
4
5
6
Next
>
End
>>
Powered by
Tags for Joomla
Top Topics
access to medicines
canada
chronic disease
disease management
global health
health policy
health spending
importation
innovation
usa
Latest News
Canada is slow to adopt innovative medicines, according to new study
Global partnerships working to eradicate malaria - World Malaria Day 2010
Pharmacy reform in Ontario to address overpriced generic medicines
Counterfeit medicines threaten public health in Peru
Summary Report: Benefit-Risk Roundtable
Popular Articles
Global partnerships facilitate access to medicines
Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
Case studies for global health
Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
2008 UNAIDS report highlights decrease in global rate of infections; role of life-saving drugs
Social Media
Login
Username:
Password:
Remember Me
Forgot your password?
Forgot your username?
Create an account
Who's Online
We have
118 guests
online
Latest Events
No events
copyright © World Health Advocacy Inc.